/>i
In the latest episode of Health Law Diagnosed, Of Counsel Bridgette Keller is joined by Associate Hassan Shaikh for a discussion on noteworthy developments relating to the IRA and drug pricing.
Together, Bridgette and Hassan explore:
- The expansion and evolution of the Medicare Drug Price Negotiation Program
- Court challenges to the Negotiation Program
- Drug pricing reform and the OBBBA
- Impacts on patients and hospitals related to Medicare Part D, 340B, and OPPS clawbacks
- The rise of direct-to-consumer drug sales models
